1% OPA-15406

DRUG2 trials

Sponsors

Otsuka Pharmaceutical Co., Ltd.

Conditions

Atopic Dermatitis

Phase 3

Comparison Trial of OPA-15406 Ointment in Adult Patients With Atopic DermatitisSyndrome

CompletedNCT03908970

Otsuka Pharmaceutical Co., Ltd.Atopic Dermatitis

Start: 2019-03-25End: 2019-12-28Updated: 2021-01-25

Comparison Trial of OPA-15406 Ointment in Pediatric Patients With Atopic Dermatitis

CompletedNCT03911401

Otsuka Pharmaceutical Co., Ltd.Atopic Dermatitis

Start: 2019-05-07End: 2019-12-13Updated: 2021-01-25